Page last updated: 2024-08-17

medroxyprogesterone acetate and Placenta Increta

medroxyprogesterone acetate has been researched along with Placenta Increta in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Fukuma, Y; Hamuro, A; Hasegawa, K; Ikenoue, S; Kasuga, Y; Ochiai, D; Oishi, M; Tamai, J; Tanaka, M; Tanaka, Y; Yamagami, W; Yoshimura, T1

Other Studies

1 other study(ies) available for medroxyprogesterone acetate and Placenta Increta

ArticleYear
Obstetric outcomes after medroxyprogesterone acetate treatment for early stage endometrial cancer or atypical endometrial hyperplasia: a single hospital-based study.
    International journal of clinical oncology, 2023, Volume: 28, Issue:4

    Topics: Adult; Dilatation and Curettage; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Hospitals; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Staging; Obstetrics; Placenta Accreta; Pregnancy; Premature Birth; Retrospective Studies

2023